Co-Founded by Eric Lefkofsky Tempus Labs Addresses a Variety of Health Issues

Eric Lefkofsky is a lawyer by training holding a Juris Doctor from the University of Michigan Law School. A humanitarian by nature he and wife Liz co-founded the Lefkofsky Family Foundation. The LFF supports a variety of causes and organizations.

Arts and Culture-Steppenwolf Theatre Company and the Art Institute of Chicago.
Medicine-The Lurie Children’s Hospital in Chicago. Education-The Museum of Science and Industry and World Business Chicago. Eric serves as a Trustees for each of the organizations listed above.

An entrepreneur by profession Eric has co-founded five companies mostly in the field of business-related technology. Each company offers different services including funding for disruptive technologies, print and promotional solutions, logistics outsourcing, an analytics platform, and media procurement technology.

Three years ago Eric Lefkofsky co-founded Tempus Labs. Working with the National Cancer Institute Tempus’ objective is to better treat current and future cancer patients utilizing data gathered during the treatment of previous cancer patients.

The system Tempus created collects, analyses, and organizes data. Algorithms are generated that enable clinicians to determine a course of treatment. The Image Recognition feature uses radiological images and pathology reports to provide greater accuracy in forming a prognosis.

The medical advances Tempus has made are not limited to cancer treatment. The company’s work in gene therapy and gene editing have created treatments for two diseases that were previously classified as “untreatable”.

Gene therapy has proven effective in treating a genetic anomaly that leads to blindness. Gene editing has been tested as a treatment for Hunter Syndrome an illness that affects the skeletal, nervous, respiratory, and muscular systems. The results are still pending.

Tempus has developed a program that uses collected data to treat eye disease. The algorithms the system generates could conceivably detect ailments of the eye with greater accuracy and at a lower cost than eye care professionals.

Smart Watches have been turned into medical devices through Tempus’ efforts. The FDA has cleared a smartwatch that monitors blood pressure. Blood sugar information can be sent to smartphones and watches via two recently developed glucose meters.

About Eric Lefkofsky : www.lightbank.com/team/eric-lefkofsky